Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Inula racemosa has been traditionally used in Ayurveda and Unani systems of medicine to support respiratory health, including conditions like asthma, cough, and bronchitis. Its use for emphysema is extrapolated from its general application as a respiratory tonic and expectorant, rather than specific evidence for this chronic lung disease. The roots of Inula racemosa contain bioactive compounds such as alantolactone and isoalantolactone, which are believed to have anti-inflammatory, bronchodilatory, and expectorant properties. These constituents may help alleviate symptoms like cough and breathlessness by reducing inflammation and promoting mucus clearance.

However, scientific validation for its use specifically in emphysema is limited. Most of the available evidence is preclinical, with studies in animal models or in vitro systems suggesting anti-inflammatory and antiasthmatic effects. There are no robust human clinical trials directly evaluating Inula racemosa in emphysema patients. Its traditional use in respiratory ailments provides the basis for its continued application, but the quality of evidence for emphysema specifically is weak (rated 2/5). If considering its use, it should be as an adjunct to, not a replacement for, evidence-based medical therapy, and under the supervision of a qualified healthcare provider.

More about inula racemosa
More about Emphysema

Other ingredients used for Emphysema

Other health conditions supported by inula racemosa

Products containing inula racemosa